CARMIL2
Basic information
Region (hg38): 16:67644988-67657569
Previous symbols: [ "RLTPR" ]
Links
Phenotypes
GenCC
Source:
- severe combined immunodeficiency due to CARMIL2 deficiency (Moderate), mode of inheritance: AR
- severe combined immunodeficiency due to CARMIL2 deficiency (Strong), mode of inheritance: AR
- severe combined immunodeficiency due to CARMIL2 deficiency (Supportive), mode of inheritance: AR
- severe combined immunodeficiency due to CARMIL2 deficiency (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunodeficiency 58 | AR | Allergy/Immunology/Infectious; Oncologic | Individuals may have severe and frequent infections, and prophylactic measures, as well as early and aggressive treatment of infections may be beneficial; Individuals may be at increased risk of certain types of neoplasms, and awareness may allow prompt diagnosis and management | Allergy/Immunology/Infectious; Dermatologic; Oncologic; Pulmonary | 27647349; 27896283; 28112205; 29479355 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (1043 variants)
- Severe_combined_immunodeficiency_due_to_CARMIL2_deficiency (38 variants)
- CARMIL2-related_disorder (37 variants)
- Inborn_genetic_diseases (11 variants)
- Combined_immunodeficiency (3 variants)
- not_specified (2 variants)
- Autosomal_recessive_congenital_ichthyosis (1 variants)
- Chronic_colitis (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CARMIL2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001013838.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 286 | 301 | ||||
missense | 401 | 16 | 431 | |||
nonsense | 19 | 24 | ||||
start loss | 0 | |||||
frameshift | 23 | 29 | ||||
splice donor/acceptor (+/-2bp) | 11 | 13 | ||||
Total | 45 | 24 | 411 | 302 | 16 |
Highest pathogenic variant AF is 0.0000487285
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CARMIL2 | protein_coding | protein_coding | ENST00000334583 | 38 | 12651 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.93e-11 | 1.00 | 124971 | 0 | 56 | 125027 | 0.000224 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.57 | 703 | 831 | 0.846 | 0.0000522 | 9032 |
Missense in Polyphen | 179 | 236.34 | 0.7574 | 2931 | ||
Synonymous | 0.774 | 346 | 365 | 0.948 | 0.0000242 | 3095 |
Loss of Function | 4.81 | 32 | 77.8 | 0.411 | 0.00000445 | 803 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000645 | 0.000600 |
Ashkenazi Jewish | 0.0000996 | 0.0000993 |
East Asian | 0.000294 | 0.000274 |
Finnish | 0.0000929 | 0.0000926 |
European (Non-Finnish) | 0.000286 | 0.000256 |
Middle Eastern | 0.000294 | 0.000274 |
South Asian | 0.000236 | 0.000229 |
Other | 0.000172 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Cell membrane-cytoskeleton-associated protein that plays a role in the regulation of actin polymerization at the barbed end of actin filaments. Prevents F-actin heterodimeric capping protein (CP) activity at the leading edges of migrating cells, and hence generates uncapped barbed ends and enhances actin polymerization (PubMed:26466680). Plays a role in cell protrusion formations; involved in cell polarity, lamellipodial assembly, membrane ruffling and macropinosome formations (PubMed:19846667, PubMed:26578515, PubMed:26466680). Involved as well in cell migration and invadopodia formation during wound healing (PubMed:19846667, PubMed:26578515, PubMed:26466680). {ECO:0000269|PubMed:19846667, ECO:0000269|PubMed:26466680, ECO:0000269|PubMed:26578515}.;
Recessive Scores
- pRec
- 0.0922
Intolerance Scores
- loftool
- rvis_EVS
- -1.12
- rvis_percentile_EVS
- 6.61
Haploinsufficiency Scores
- pHI
- 0.228
- hipred
- N
- hipred_score
- 0.429
- ghis
- 0.614
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Carmil2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; pigmentation phenotype; vision/eye phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- establishment or maintenance of cell polarity;positive regulation of lamellipodium assembly;maintenance of cell polarity;positive regulation of cell migration;wound healing, spreading of cells;actin filament network formation;establishment or maintenance of monopolar cell polarity;positive regulation of extracellular matrix disassembly;positive regulation of ruffle assembly;positive regulation of lamellipodium organization;negative regulation of barbed-end actin filament capping
- Cellular component
- ruffle;cytoplasm;plasma membrane;actin cytoskeleton;membrane;lamellipodium;extrinsic component of cytoplasmic side of plasma membrane;cell leading edge;macropinosome;intermediate filament cytoskeleton
- Molecular function
- phospholipid binding;protein-containing complex binding